EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Refractory Bullous Pemphigoid Treated with Intermittent Dosing of Omalizumab

Rebecca Kai Jan Choong, Nik Aimee Azizah Faheem, Winn Hui Han, Zhenli Kwan

Malaysian Journal of Dermatology · 2025

DOI: 10.4103/mjd.mjd_24_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Malaysian Journal of Dermatology, 2025. Verfasst von Rebecca Kai Jan Choong und 3 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bullous pemphigoid (BP) is a chronic autoimmune blistering disease that typically presents in older adults and is characterised by tense, pruritic blisters. Standard treatment includes corticosteroids and immunosuppressive agents, but refractory cases may necessitate adjunctive therapies, including biologics. We report a case of a 28-year-old male with refractory BP successfully managed with omalizumab, a monoclonal anti-immunoglobulin E antibody used in allergic conditions but showing promise as an adjunctive therapy for severe BP. This case illustrates the potential role of intermittent doses of subcutaneous omalizumab which is more cost-effective compared to continuous treatment, while still improving outcomes in patients with treatment-resistant BP.

Zitieren

APA

Choong, R. K. J., Faheem, N. A. A., Han, W. H., & Kwan, Z. (2025). Refractory Bullous Pemphigoid Treated with Intermittent Dosing of Omalizumab. Malaysian Journal of Dermatology. https://doi.org/10.4103/mjd.mjd_24_24

Vancouver

Choong RKJ, Faheem NAA, Han WH, Kwan Z. Refractory Bullous Pemphigoid Treated with Intermittent Dosing of Omalizumab. Malaysian Journal of Dermatology. 2025. doi:10.4103/mjd.mjd_24_24

BibTeX
@article{Choong2025,
  author = {Choong, Rebecca Kai Jan and Faheem, Nik Aimee Azizah and Han, Winn Hui and Kwan, Zhenli},
  title = {Refractory Bullous Pemphigoid Treated with Intermittent Dosing of Omalizumab},
  journal = {Malaysian Journal of Dermatology},
  year = {2025},
  doi = {10.4103/mjd.mjd_24_24}
}
Kostenlos starten →